OKEY STEPHANIE sold 51.9% of their position (6.90K shares) of CRINETICS PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $246.1K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 6/18/2026ACC: 0001628280-26-044419
Director
Since Jul 2019
-6.90K
Net shares
Net seller
$246.1K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
6.90K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−6.29K
Price / share
$35.62
Trade value
$224.12K
% of position
47.3%
6/17/2026
13.30K→7.01K
Common Stock
Direct
Shares
−608.00
Price / share
$36.22
Trade value
$22.02K
% of position
8.7%
6/17/2026
7.01K→6.40K
Total
Net shares
−6.90K
Net value
-$246.14K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/17/2026 | S · Sale | −6.29K | $35.62 | $224.12K | 47.3% | 13.30K | 7.01K |
| Common Stock Direct | 6/17/2026 | S · Sale | −608.00 | $36.22 | $22.02K | 8.7% | 7.01K | 6.40K |
| Total | −6.90K | -$246.14K | ||||||
Derivative Transactions0
No derivative transactions reported